MAP2 and Alzheimer disease: In contrast, although MSCs possess multi-differentiation capacity, none of TH or MAP2 phenotypes could be observed in MLN-EGFP or EGFP-infected UC-MSCs (Figure 2C) or AD-MSCs (Figure 2D).